BIOCAPTIVA has been awarded its first US patent for its liquid biopsy technology. The solution aims to efficiently capture cell-free DNA (cfDNA) directly from bodily fluids. As a result, the biotech company hopes to...

ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of 2.5 million GBP.  The fundraise,...

Novartis, a developer of radiopharmaceuticals currently selling Pluvicto and Lutathera to treat prostate and digestive tract cancers, has announced its upcoming expansion plans. Joining the company’s current facilities in New Jersey and Indianapolis, Novartis...

NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a 10 million GBP (13 million USD) financing round.  The...

The Chiesi Group has revealed its new Senior Vice President of Global Communications & Public Affairs, Lauren Vergani. Vergani, who has previously held senior roles at leading global companies such as Walgreens Boots Alliance,...

Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has announced the launch of its proprietary CiliaBeat software and application...

Gerresheimer will be presenting its silicone oil-free prefillable syringe systems for ophthalmic applications at CPHI Worldwide 2024. The syringe systems made of glass or plastic are designed for maximum compatibility even for sensitive ophthalmic...

Renato Rjavec, ArisGlobal, discusses how generative AI (GenAI) technology is transforming everyday regulatory and safety processes, thanks to its ability to summarise key insights and findings from across huge, diverse bodies of content and...

Automated Material Processing (AMP), comprising Kason Corporation and Marion Process Solutions, has recently introduced its TotalClean Clean-in-Place (CIP) systems. These CIP solutions are designed to increase efficiency, safety and profitability across a range of industries...

A new home pin-prick blood test, The Glutathione Index test, has launched – and it can predict dementia risk. Your brain consumes more energy than any other organ. This combustion creates exhaust – oxidants...

BlueRock Therapeutics, a clinical stage cell therapy company and wholly owned, independently operated subsidiary of Bayer, has announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA)...

Johnson & Johnson (J&J) has submitted its nipocalimab drug for approval from the US Food and Drug Administration (FDA). While the initial submission relates to use with patients with generalised myasthenia gravis, the company believes...

Novavax has announced that it has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). The ruling relates to the updated version of its Covid-19 vaccine, NVX-CoV2705. This news follows...

Vetter, a leading global contract development and manufacturing organisation (CDMO), has successfully completed the first 100 clinical batches of liquid and lyophilised vials at its dedicated site in Rankweil, Austria. Vetter Development Services Austria...

The Medicines and Healthcare Products Regulatory Agency (MHRA) has given its authorisation of Moderna’s updated Covid-19 vaccine. The latest innovation of the vaccine aims to target the JN.1 variant of SARS-CoV-2. Doses of the...

SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis, has announced the granting of an Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for its drug candidate SBL01 in the...

Novartis and Lindy Biosciences sign a licensing and collaboration agreement that will improve biologic delivery. The North Carolina-based biotech company will help deliver biologics via subcutaneous (SC) injections, which can be self-administered at home....

Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, has announced that it has completed the Phase 1 clinical...